Brain-derived neurotrophic factor (BDNF) was significantly downregulated in the asthma cohort following benralizumab treatment (FDR < 0.05), although the magnitude of change was modest (10% decrease post-treatment) (Additional file 4: Figure S3). The gene discussed is BDNF; the disease is asthma.